Royal Bank of Canada Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $15.00

Wave Life Sciences (NASDAQ:WVE – Get Free Report) had its price target boosted by research analysts at Royal Bank of Canada from $7.00 to $15.00 in a report issued on Monday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price suggests a potential downside of […]

Leave a Reply

Your email address will not be published.

Previous post U.S. Bancorp (NYSE:USB) Shares Sold by Koss Olinger Consulting LLC
Next post Oklahoma Bank Shut Down by Regulator in 2nd Bank Failure of the Year